Javier Diez-Domingo, MD, PhD

FISABIO Fundación para el Fomento Investigación Sanitaria y Biomédica de la Comunitat Valenciana, Spain

Disclosure(s): GSK: Grant/Research Support, Honoraria; MSD: Advisor/Consultant, Consulting fees to the author and his institution, Grant/Research Support; SANOFI: Advisor/Consultant, Grant/Research Support; SANOFI PASTEUR: Consulting fees to the author and his institution; SEQIRUS: Honoraria, Honoraria to the author and his institution

Poster(s):

• 114 - Long-term Protection Against Herpes Zoster (HZ) by the Adjuvanted Recombinant Zoster Vaccine (RZV): Interim Efficacy, Immuno and Safety Results at Approximately 10 Years after Initial Vaccination
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET